Related Experiment Video
Updated: Mar 29, 2026
08:31
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
5.6K
The 3rd China Bioanalysis Forum annual meeting
Daniel Tang1, Dafang Zhong2, Kelly Dong3
1United-Power PharmaTech, Life Park Road, Changping District, Beijing.
Bioanalysis
|November 25, 2015
Summary
The 2015 China Bioanalysis Forum addressed biologics, biomarkers, and regulatory bioanalytical issues. Key challenges and advancements in these areas were discussed by over 150 experts from diverse scientific sectors.
Area of Science:
- Pharmaceutical Science
- Biotechnology
- Analytical Chemistry
Background:
- The 3rd China Bioanalysis Forum convened in Shanghai in June 2015.
- The conference gathered over 150 professionals from the pharmaceutical and biotechnology industries, contract research organizations (CROs), clinical research centers, research institutes, and regulatory agencies.
Purpose of the Study:
- To summarize the principal discussion points from the 2015 China Bioanalysis Forum.
- To highlight key topics in biologics, biomarkers, and regulated bioanalytical challenges.
Main Methods:
- The report is a summary of discussions held at the conference.
- Key themes were identified from the forum's proceedings.
Main Results:
- Discussions centered on critical aspects of biologics development and analysis.
- Biomarker strategies and their validation were a significant focus.
- Regulated bioanalytical challenges, including method validation and regulatory compliance, were extensively debated.
Conclusions:
- The forum successfully convened experts to discuss pressing issues in bioanalysis.
- Advancements and challenges in biologics, biomarkers, and regulated bioanalysis were identified.
- The event facilitated knowledge exchange among industry, research, and regulatory stakeholders.
